table of content
1 Introduction to Research & Analysis Reports
1.1 Preclinical In-vivo Imaging System Market Definition
1.2 Market Segments
1.2.1 Segment by Imaging Modality Type
1.2.2 Segment by Product Form Type
1.2.3 Segment by Technology Integration Type
1.2.4 Segment by Application
1.3 Global Preclinical In-vivo Imaging System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Preclinical In-vivo Imaging System Overall Market Size
2.1 Global Preclinical In-vivo Imaging System Market Size: 2025 VS 2034
2.2 Global Preclinical In-vivo Imaging System Market Size, Prospects & Forecasts: 2021-2034
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Preclinical In-vivo Imaging System Players in Global Market
3.2 Top Global Preclinical In-vivo Imaging System Companies Ranked by Revenue
3.3 Global Preclinical In-vivo Imaging System Revenue by Companies
3.4 Top 3 and Top 5 Preclinical In-vivo Imaging System Companies in Global Market, by Revenue in 2025
3.5 Global Companies Preclinical In-vivo Imaging System Product Type
3.6 Tier 1, Tier 2, and Tier 3 Preclinical In-vivo Imaging System Players in Global Market
3.6.1 List of Global Tier 1 Preclinical In-vivo Imaging System Companies
3.6.2 List of Global Tier 2 and Tier 3 Preclinical In-vivo Imaging System Companies
4 Sights by Imaging Modality Type
4.1 Overview
4.1.1 Segmentation by Imaging Modality Type - Global Preclinical In-vivo Imaging System Market Size Markets, 2025 & 2034
4.1.2 Optical Imaging Systems
4.1.3 Magnetic Resonance Imaging (MRI) Systems
4.1.4 Computed Tomography (CT) Systems
4.1.5 Positron Emission Tomography (PET) Systems
4.1.6 Others
4.2 Segmentation by Imaging Modality Type - Global Preclinical In-vivo Imaging System Revenue & Forecasts
4.2.1 Segmentation by Imaging Modality Type - Global Preclinical In-vivo Imaging System Revenue, 2021-2026
4.2.2 Segmentation by Imaging Modality Type - Global Preclinical In-vivo Imaging System Revenue, 2027-2034
4.2.3 Segmentation by Imaging Modality Type - Global Preclinical In-vivo Imaging System Revenue Market Share, 2021-2034
5 Sights by Product Form Type
5.1 Overview
5.1.1 Segmentation by Product Form Type - Global Preclinical In-vivo Imaging System Market Size Markets, 2025 & 2034
5.1.2 Standalone Imaging Systems
5.1.3 Hybrid Imaging Systems
5.1.4 Tabletop/Benchtop Systems
5.1.5 Others
5.2 Segmentation by Product Form Type - Global Preclinical In-vivo Imaging System Revenue & Forecasts
5.2.1 Segmentation by Product Form Type - Global Preclinical In-vivo Imaging System Revenue, 2021-2026
5.2.2 Segmentation by Product Form Type - Global Preclinical In-vivo Imaging System Revenue, 2027-2034
5.2.3 Segmentation by Product Form Type - Global Preclinical In-vivo Imaging System Revenue Market Share, 2021-2034
6 Sights by Technology Integration Type
6.1 Overview
6.1.1 Segmentation by Technology Integration Type - Global Preclinical In-vivo Imaging System Market Size Markets, 2025 & 2034
6.1.2 Fully Automated Imaging Systems
6.1.3 Semi-Automated Imaging Systems
6.2 Segmentation by Technology Integration Type - Global Preclinical In-vivo Imaging System Revenue & Forecasts
6.2.1 Segmentation by Technology Integration Type - Global Preclinical In-vivo Imaging System Revenue, 2021-2026
6.2.2 Segmentation by Technology Integration Type - Global Preclinical In-vivo Imaging System Revenue, 2027-2034
6.2.3 Segmentation by Technology Integration Type - Global Preclinical In-vivo Imaging System Revenue Market Share, 2021-2034
7 Sights by Application
7.1 Overview
7.1.1 Segmentation by Application - Global Preclinical In-vivo Imaging System Market Size, 2025 & 2034
7.1.2 Oncology Research
7.1.3 Cardiovascular Research
7.1.4 Neurological and Brain Research
7.1.5 Metabolic and Obesity Studies
7.1.6 Others
7.2 Segmentation by Application - Global Preclinical In-vivo Imaging System Revenue & Forecasts
7.2.1 Segmentation by Application - Global Preclinical In-vivo Imaging System Revenue, 2021-2026
7.2.2 Segmentation by Application - Global Preclinical In-vivo Imaging System Revenue, 2027-2034
7.2.3 Segmentation by Application - Global Preclinical In-vivo Imaging System Revenue Market Share, 2021-2034
8 Sights Region
8.1 By Region - Global Preclinical In-vivo Imaging System Market Size, 2025 & 2034
8.2 By Region - Global Preclinical In-vivo Imaging System Revenue & Forecasts
8.2.1 By Region - Global Preclinical In-vivo Imaging System Revenue, 2021-2026
8.2.2 By Region - Global Preclinical In-vivo Imaging System Revenue, 2027-2034
8.2.3 By Region - Global Preclinical In-vivo Imaging System Revenue Market Share, 2021-2034
8.3 North America
8.3.1 By Country - North America Preclinical In-vivo Imaging System Revenue, 2021-2034
8.3.2 United States Preclinical In-vivo Imaging System Market Size, 2021-2034
8.3.3 Canada Preclinical In-vivo Imaging System Market Size, 2021-2034
8.3.4 Mexico Preclinical In-vivo Imaging System Market Size, 2021-2034
8.4 Europe
8.4.1 By Country - Europe Preclinical In-vivo Imaging System Revenue, 2021-2034
8.4.2 Germany Preclinical In-vivo Imaging System Market Size, 2021-2034
8.4.3 France Preclinical In-vivo Imaging System Market Size, 2021-2034
8.4.4 U.K. Preclinical In-vivo Imaging System Market Size, 2021-2034
8.4.5 Italy Preclinical In-vivo Imaging System Market Size, 2021-2034
8.4.6 Russia Preclinical In-vivo Imaging System Market Size, 2021-2034
8.4.7 Nordic Countries Preclinical In-vivo Imaging System Market Size, 2021-2034
8.4.8 Benelux Preclinical In-vivo Imaging System Market Size, 2021-2034
8.5 Asia
8.5.1 By Region - Asia Preclinical In-vivo Imaging System Revenue, 2021-2034
8.5.2 China Preclinical In-vivo Imaging System Market Size, 2021-2034
8.5.3 Japan Preclinical In-vivo Imaging System Market Size, 2021-2034
8.5.4 South Korea Preclinical In-vivo Imaging System Market Size, 2021-2034
8.5.5 Southeast Asia Preclinical In-vivo Imaging System Market Size, 2021-2034
8.5.6 India Preclinical In-vivo Imaging System Market Size, 2021-2034
8.6 South America
8.6.1 By Country - South America Preclinical In-vivo Imaging System Revenue, 2021-2034
8.6.2 Brazil Preclinical In-vivo Imaging System Market Size, 2021-2034
8.6.3 Argentina Preclinical In-vivo Imaging System Market Size, 2021-2034
8.7 Middle East & Africa
8.7.1 By Country - Middle East & Africa Preclinical In-vivo Imaging System Revenue, 2021-2034
8.7.2 Turkey Preclinical In-vivo Imaging System Market Size, 2021-2034
8.7.3 Israel Preclinical In-vivo Imaging System Market Size, 2021-2034
8.7.4 Saudi Arabia Preclinical In-vivo Imaging System Market Size, 2021-2034
8.7.5 UAE Preclinical In-vivo Imaging System Market Size, 2021-2034
9 Companies Profiles
9.1 Bruker Corporation
9.1.1 Bruker Corporation Corporate Summary
9.1.2 Bruker Corporation Business Overview
9.1.3 Bruker Corporation Preclinical In-vivo Imaging System Major Product Offerings
9.1.4 Bruker Corporation Preclinical In-vivo Imaging System Revenue in Global Market (2021-2026)
9.1.5 Bruker Corporation Key News & Latest Developments
9.2 PerkinElmer
9.2.1 PerkinElmer Corporate Summary
9.2.2 PerkinElmer Business Overview
9.2.3 PerkinElmer Preclinical In-vivo Imaging System Major Product Offerings
9.2.4 PerkinElmer Preclinical In-vivo Imaging System Revenue in Global Market (2021-2026)
9.2.5 PerkinElmer Key News & Latest Developments
9.3 FUJIFILM
9.3.1 FUJIFILM Corporate Summary
9.3.2 FUJIFILM Business Overview
9.3.3 FUJIFILM Preclinical In-vivo Imaging System Major Product Offerings
9.3.4 FUJIFILM Preclinical In-vivo Imaging System Revenue in Global Market (2021-2026)
9.3.5 FUJIFILM Key News & Latest Developments
9.4 Siemens AG
9.4.1 Siemens AG Corporate Summary
9.4.2 Siemens AG Business Overview
9.4.3 Siemens AG Preclinical In-vivo Imaging System Major Product Offerings
9.4.4 Siemens AG Preclinical In-vivo Imaging System Revenue in Global Market (2021-2026)
9.4.5 Siemens AG Key News & Latest Developments
9.5 GE Healthcare
9.5.1 GE Healthcare Corporate Summary
9.5.2 GE Healthcare Business Overview
9.5.3 GE Healthcare Preclinical In-vivo Imaging System Major Product Offerings
9.5.4 GE Healthcare Preclinical In-vivo Imaging System Revenue in Global Market (2021-2026)
9.5.5 GE Healthcare Key News & Latest Developments
9.6 United Imaging
9.6.1 United Imaging Corporate Summary
9.6.2 United Imaging Business Overview
9.6.3 United Imaging Preclinical In-vivo Imaging System Major Product Offerings
9.6.4 United Imaging Preclinical In-vivo Imaging System Revenue in Global Market (2021-2026)
9.6.5 United Imaging Key News & Latest Developments
9.7 Aspect Imaging
9.7.1 Aspect Imaging Corporate Summary
9.7.2 Aspect Imaging Business Overview
9.7.3 Aspect Imaging Preclinical In-vivo Imaging System Major Product Offerings
9.7.4 Aspect Imaging Preclinical In-vivo Imaging System Revenue in Global Market (2021-2026)
9.7.5 Aspect Imaging Key News & Latest Developments
9.8 Biospace Lab SA
9.8.1 Biospace Lab SA Corporate Summary
9.8.2 Biospace Lab SA Business Overview
9.8.3 Biospace Lab SA Preclinical In-vivo Imaging System Major Product Offerings
9.8.4 Biospace Lab SA Preclinical In-vivo Imaging System Revenue in Global Market (2021-2026)
9.8.5 Biospace Lab SA Key News & Latest Developments
9.9 MR Solutions Ltd
9.9.1 MR Solutions Ltd Corporate Summary
9.9.2 MR Solutions Ltd Business Overview
9.9.3 MR Solutions Ltd Preclinical In-vivo Imaging System Major Product Offerings
9.9.4 MR Solutions Ltd Preclinical In-vivo Imaging System Revenue in Global Market (2021-2026)
9.9.5 MR Solutions Ltd Key News & Latest Developments
9.10 Mediso Ltd
9.10.1 Mediso Ltd Corporate Summary
9.10.2 Mediso Ltd Business Overview
9.10.3 Mediso Ltd Preclinical In-vivo Imaging System Major Product Offerings
9.10.4 Mediso Ltd Preclinical In-vivo Imaging System Revenue in Global Market (2021-2026)
9.10.5 Mediso Ltd Key News & Latest Developments
9.11 Shimadzu Corporation
9.11.1 Shimadzu Corporation Corporate Summary
9.11.2 Shimadzu Corporation Business Overview
9.11.3 Shimadzu Corporation Preclinical In-vivo Imaging System Major Product Offerings
9.11.4 Shimadzu Corporation Preclinical In-vivo Imaging System Revenue in Global Market (2021-2026)
9.11.5 Shimadzu Corporation Key News & Latest Developments
9.12 Hitachi High-Tech Corporation
9.12.1 Hitachi High-Tech Corporation Corporate Summary
9.12.2 Hitachi High-Tech Corporation Business Overview
9.12.3 Hitachi High-Tech Corporation Preclinical In-vivo Imaging System Major Product Offerings
9.12.4 Hitachi High-Tech Corporation Preclinical In-vivo Imaging System Revenue in Global Market (2021-2026)
9.12.5 Hitachi High-Tech Corporation Key News & Latest Developments
9.13 Toshiba / Canon Medical Systems
9.13.1 Toshiba / Canon Medical Systems Corporate Summary
9.13.2 Toshiba / Canon Medical Systems Business Overview
9.13.3 Toshiba / Canon Medical Systems Preclinical In-vivo Imaging System Major Product Offerings
9.13.4 Toshiba / Canon Medical Systems Preclinical In-vivo Imaging System Revenue in Global Market (2021-2026)
9.13.5 Toshiba / Canon Medical Systems Key News & Latest Developments
9.14 Olympus Corporation
9.14.1 Olympus Corporation Corporate Summary
9.14.2 Olympus Corporation Business Overview
9.14.3 Olympus Corporation Preclinical In-vivo Imaging System Major Product Offerings
9.14.4 Olympus Corporation Preclinical In-vivo Imaging System Revenue in Global Market (2021-2026)
9.14.5 Olympus Corporation Key News & Latest Developments
9.15 Neusoft Medical
9.15.1 Neusoft Medical Corporate Summary
9.15.2 Neusoft Medical Business Overview
9.15.3 Neusoft Medical Preclinical In-vivo Imaging System Major Product Offerings
9.15.4 Neusoft Medical Preclinical In-vivo Imaging System Revenue in Global Market (2021-2026)
9.15.5 Neusoft Medical Key News & Latest Developments
9.16 Sontu
9.16.1 Sontu Corporate Summary
9.16.2 Sontu Business Overview
9.16.3 Sontu Preclinical In-vivo Imaging System Major Product Offerings
9.16.4 Sontu Preclinical In-vivo Imaging System Revenue in Global Market (2021-2026)
9.16.5 Sontu Key News & Latest Developments
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
